UNSPSC 51192204: Hydrochlorothiazide/triamterene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV704. This VA Drug Class (CV704) classifies this compound as belonging to the group POTASSIUM SPARING/COMBINATIONS DIURETICS.

UNSPSC 51192204 Hydrochlorothiazide/triamterene is a Commodity code that in recent state and local procurement activity covers generic pharmaceuticals and over-the-counter products supplied through cooperative purchasing frameworks, though the code's nominal scope and the actual work being solicited show significant divergence. State and local governments use this code to procure multi-source generic medications and OTC products for distribution across health departments, correctional facilities, municipal clinics, and other government healthcare operations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, has recently issued a Request for Proposal to establish blanket contracts for generic multi-source pharmaceuticals and OTC products, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC) and to certify compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act. Vendors must provide detailed product information by National Drug Code, SKU, UPC, dosage form, and manufacturing location, with pricing evaluated 75 percent on competitiveness, 10 percent on fixed-price stability over the contract term, and the remainder on administrative compliance and EDI capability. Insurers must carry commercial general liability of $5,000,000 per occurrence, network security and privacy liability of $2,000,000, and professional liability of $2,000,000.

The recent-opportunities block shows minimal alignment between the code's name and actual procurement activity. The City of Meriden, Connecticut issued an IFB for sodium bisulfite chemical supply for water treatment (Solicitation B027-15, due July 29, 2026), which is unrelated to pharmaceutical or OTC product procurement. The MMCAP RFP (Solicitation S1070000015802, due March 26, 2026) represents the substantive recent activity under this code, covering participating state and local government facilities across Minnesota and Oregon on a multi-year contract effective July 1, 2026. The code shows activity from state cooperative purchasing entities and municipal procurement offices, with no repeat buyers indicated in the recent opportunities block beyond MMCAP's multi-state coordination. No other states appear in the recent-opportunities summary; activity is concentrated in Minnesota through MMCAP's framework.